ASLAN Pharmaceuticals Statistics

Total Valuation

ASLN has a market cap or net worth of $1.70 million. The enterprise value is $9.97 million.

Market Cap	1.70M
Enterprise Value	9.97M

Important Dates

The last earnings date was Friday, August 9, 2024, before market open.

Earnings Date	Aug 9, 2024
Ex-Dividend Date	n/a

Share Statistics

ASLN has 2.83 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	2.83M
Owned by Insiders (%)	0.14%
Owned by Institutions (%)	13.21%
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.14
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	0.83
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.05

Current Ratio	1.05
Quick Ratio	n/a
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-7.90

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-96.30%
Return on Capital (ROIC)	-401.40%
Revenue Per Employee	$342,857
Profits Per Employee	-$1.00M
Employee Count	35
Asset Turnover	0.33
Inventory Turnover	n/a

Taxes

In the past 12 months, ASLN has paid $126,074 in taxes.

Income Tax	126,074
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -97.15% in the last 52 weeks. The beta is 1.40, so ASLN's price volatility has been higher than the market average.

Beta (5Y)	1.40
52-Week Price Change	-97.15%
50-Day Moving Average	2.61
200-Day Moving Average	4.85
Relative Strength Index (RSI)	21.69
Average Volume (20 Days)	284,891

Short Selling Information

Short Interest	306,565
Short Previous Month	269,900
Short % of Shares Out	1.46%
Short % of Float	n/a
Short Ratio (days to cover)	1.85

Income Statement

In the last 12 months, ASLN had revenue of $12.00 million and -$35.03 million in losses. Loss per share was -$14.00.

Revenue	12.00M
Gross Profit	12.00M
Operating Income	-34.92M
Pretax Income	-34.90M
Net Income	-35.03M
EBITDA	n/a
EBIT	-30.98M
Loss Per Share	-$14.00

Full Income Statement

Balance Sheet

The company has $18.40 million in cash and $26.67 million in debt, giving a net cash position of -$8.27 million or -$2.92 per share.

Cash & Cash Equivalents	18.40M
Total Debt	26.67M
Net Cash	-8.27M
Net Cash Per Share	-$2.92
Equity (Book Value)	-17.96M
Book Value Per Share	-6.35
Working Capital	972,048

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of -291.03% and -291.89%.

Gross Margin	100.00%
Operating Margin	-291.03%
Pretax Margin	-290.84%
Profit Margin	-291.89%
EBITDA Margin	n/a
EBIT Margin	-258.15%
FCF Margin	n/a

Dividends & Yields

ASLN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-25.91%
Shareholder Yield	-25.91%
Earnings Yield	-2,064.03%
FCF Yield	n/a

Analyst Forecast

The average price target for ASLN is $90.67, which is 15,011.67% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$90.67
Price Target Difference	15,011.67%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on July 3, 2024. It was a reverse split with a ratio of 1:8.

Last Split Date	Jul 3, 2024
Split Type	Reverse
Split Ratio	1:8

Scores

ASLN has an Altman Z-Score of -26.3 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-26.3
Piotroski F-Score	1